
NYSE:CVS
Healthcare as not performed well this year.
Technology attracting lots of investor money in the short term.
Long term, demand for healthcare is strong.
Recent M&A and company re-organization has negatively impacted share price.
Current share price presenting value - however waiting to see how company stabilizes.
Down around 20% YOY. Really likes the vertically integrated healthcare business model. Very low valuation with high free cashflow yield. Concern is always regulation. Acquisition integration is challenged short term, but should come online longer term just fine.